CVIR Endovascular welcomes new Editor-in-Chief Prof. Rob Morgan

September 1, 2025

Since its launch in 2017, CVIR Endovascular has provided a dedicated platform for high-quality research and discussion in the ever-evolving field of minimally invasive vascular procedures. With its recent achievement of an impact factor of 1.5 and growing global readership, the journal is entering an exciting new chapter. We talked to incoming Editor-in-Chief Prof. Rob Morgan about his vision for the journal’s future, the importance of open access publishing, and the role of multidisciplinary collaboration in further strengthening CVIR Endovascular. 

CIRSE Insider: For those who do not know you yet; what is your background and what motivated you to apply for the position of CVIR Endovascular Editor in Chief?

Morgan: I am an enthusiastic academic interventional radiologist and have always had a strong interest in the role endovascular procedures have in helping patients. Over the course of my career, I have occupied several positions in the CIRSE leadership, including serving as CIRSE President from 2017-2019, where I was able to contribute to the strategic development of our field. One of my most rewarding achievements was helping establish the European Board of Interventional Radiology (EBIR) examination in 2010, which has since become an international benchmark of excellence in IR training and practice.

My editorial experience spans almost two decades, having served as Editor for Reviews for Cardiovascular and Interventional Radiology (CVIR) between 2010 and 2017. I was part of the CVIR Endovascular team from the beginning, serving as deputy editor-in-chief. I was certain that the journal was much needed and would offer an important platform for IRs with a particular interest in endovascular procedures. My editorial roles allowed me to work closely with authors and reviewers and deepened my understanding of academic publishing. Becoming Editor-in-Chief of a CIRSE journal has always been a personal aspiration, and I am genuinely delighted to now lead CVIR Endovascular. It will be a privilege to build on the foundations laid by my predecessor Prof. Jim Reekers and to help guide the journal into its next phase of growth and influence.

CIRSE Insider: Why do you feel CVIR Endovascular is important for IR?

Morgan: CVIR Endovascular plays a unique and vital role in the dissemination of knowledge in interventional radiology. Unlike more general IR journals, it is exclusively dedicated to endovascular techniques, offering a specialized platform for the latest advances in peripheral arterial and venous interventions, aortic therapies, embolization, and related procedures. By focusing specifically on endovascular therapies, the journal provides a scholarly home where clinicians, researchers, and innovators can engage with cutting-edge work that is directly relevant to their practice.

Another important factor is that the journal is fully open access. This ensures that new findings and technical innovations are freely available to the global community, including clinicians working in regions where subscription-based access might be limited. In this way, CVIR Endovascular fosters equity in knowledge dissemination, helping to raise standards of care worldwide. I firmly believe that such accessibility accelerates the pace of innovation and collaboration in our field.

CIRSE Insider: What are your plans for the journal?

Morgan: I have assembled a great team of endovascular experts to be section editors, regional editors and editorial board members. Our aims are to publish quality papers in all types of endovascular therapies. Building on the excellent foundation established by Prof. Jim Reekers and his editorial team – who brought the journal to its first Impact Factor currently at 1.5 – we now aspire to further strengthen the journal’s academic reputation.

My vision is threefold; firstly, I of course want to focus on quality, prioritizing rigorous, well-written papers that will have a tangible impact on clinical practice. Secondly, I want to to increase the journal’s visibility and international reach, ensuring contributions from across the globe are represented. Last but not least, I want the journal to be multifaceted. In addition to original research, I want the journal to feature timely reviews, perspectives, and debates that address pressing clinical and technical challenges in endovascular therapy. Ultimately, my ambition is not only to continue growing the journal’s impact factor, but also to keep pushing CVIR Endovascular as the essential forum where endovascular specialists and from related medical fields turn to share and discover transformative ideas.

CIRSE Insider: What submissions do you hope to attract?

Morgan: I hope we will attract all types of manuscripts dealing with endovascular therapies, including scientific papers, review articles, technical notes, letters to the editor, case reports, The editorial team also welcome thoughtful commentaries that can stimulate discussion within the community. Our preference will be for high quality well-written articles that will further the field of endovascular therapy. While we are open to all types of manuscripts, our preference is for papers that are both methodologically sound and of clear relevance to the endovascular community. Articles that contribute new insights, foster innovation, or have strong potential for citation will be especially valued, as they advance both the academic impact of the journal and the field as a whole.

CIRSE Insider: How do you plan to further encourage multidisciplinary involvement?

Morgan: Endovascular therapy is inherently multidisciplinary, with contributions from interventional radiologists, vascular surgeons, angiologists, cardiologists, and many other specialists. It is essential that our journal reflects this reality. CVIR Endovascular is designed to be a home for all endovascular professionals engaged in minimally invasive vascular interventions, regardless of their background or professional title.

I would very much like to attract article submissions from non-IR specialists whoever they are and wherever they work. We have vascular surgeons and angiologists on our editorial board who I want to promote CVIR Endovascular to their colleagues working in the endovascular field.

CIRSE Insider: Do you have any tips and tricks for potential authors?

Morgan: My primary advice to potential authors is to consider CVIR Endovascular as their first-choice journal when submitting work on endovascular therapy. To increase their chances of success, I encourage authors to:

• Prioritize clarity and quality: A well-structured, clearly written paper is much more likely to be appreciated by reviewers and readers alike.
• Think about relevance: Ask yourself how your paper will contribute to the endovascular community. Will it inform practice? Will it inspire future research? Will it be cited by others?
• Engage with the literature: Demonstrating how your work builds upon or challenges existing evidence strengthens its significance.
• Adhere to submission guidelines: Following formatting and ethical standards from the outset makes the review process smoother and more efficient.

Ultimately, publishing is not just about adding to one’s CV—it is about contributing to the body of knowledge that drives our field forward. We look forward to receiving manuscripts from colleagues worldwide and to working with authors to bring their best work to the community through CVIR Endovascular.